#152: Even nonobstructive CAD at CT predicts risk in symptomatic patients: CONFIRM; FDA approves EPA-only omega-3 PUFA capsule; Aggressive heart-rate control reduces radiation from CCTA; rivaroxaban gets NICE thumbs-up for DVT; BMJ: TAVI is overused

#152: Even nonobstructive CAD at CT predicts risk in symptomatic patients: CONFIRM; FDA approves EPA-only omega-3 PUFA capsule; Aggressive heart-rate control reduces radiation from CCTA; rivaroxaban gets NICE thumbs-up for DVT; BMJ analysis: TAVI is vastl

Source: Radio TheHeart.org - August 3, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts